3-n-butylphthalide (NBP) reduces apoptosis and enhances vascular endothelial growth factor (VEGF) up-regulation in diabetic rats

Neurological Research

Volumn 32, Issue 4, 2010, Pages 390-396

  Zhang, Ting ^a   Jia, Weiping ^a   Sun, Xiaojiang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Apoptosis; Diabetes; Gliocytes; NBP; VEGF

Indexed keywords

3 BUTYLPHTHALIDE; CASPASE 3; CD11B ANTIGEN; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUCOSE; STREPTOZOCIN; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BODY WEIGHT; BRAIN INJURY; CHRONIC DISEASE; CONTROLLED STUDY; GLIA; GLUCOSE BLOOD LEVEL; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; NEUROPROTECTION; NONHUMAN; QUANTITATIVE ANALYSIS; RAT; SPRAGUE DAWLEY RAT; STREPTOZOCIN DIABETES; UPREGULATION;

ANIMALS; APOPTOSIS; BENZOFURANS; CEREBRAL ARTERIES; DIABETES MELLITUS; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; GLIOSIS; HIPPOCAMPUS; MALE; NEURONS; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; STROKE; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77952145041     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164110X12670144526264     Document Type: Article

References (44)

1. Khookhor O, Bolin Q, Oshida Y, et al. Effect of Mongolian plants on in vivo insulin action in diabetic rats. Diabetes Res Clin Pract 2007; 75: 135-140
2. Feldman EL. Oxidative stress and diabetic neuropathy: a new understanding of an old problem. J Clin Invest 2003; 111: 431-433
3. Biessels GJ, Kamal A, Urban IJ, et al. Water maze learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: Effects of insulin treatment. Brain Res 1998; 800: 125-135
4. Zhang T, Pan BS, Zhao B, et al. Exacerbation of poststroke dementia by type 2 diabetes is associated with synergistic increases of beta-secretase activation and beta-amyloid generation in rat brains. Neuroscience 2009; 161: 1045-1056
5. Reagan LP, Magarinos AM, Mcewen BS. Neurological changes induced by stress in streptozotocin diabetic rats. Ann NY Acad Sci 1999; 893: 126-137
6. Wyllie AH. Apoptosis: An overview. Br Med Bull 1997; 53: 451-465
7. Hartmann A, Hunot S,Michel PP, et al. Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease. Proc Natl Acad Sci USA 2000; 97: 2875-2880
8. Li M, Ona VO, Guegan C, et al. Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model. Science 2000; 288: 335-339
9. Wellington CL, Singaraja R, Ellerby L, et al. Inhibiting caspase cleavage of huntingtin reduces toxicity and aggregate formation in neuronal and nonneuronal cells. J Biol Chem 2000; 275: 19831-19838
10. Clark RS, Kochanek PM, Watkins SC, et al. Caspase-3 mediated neuronal death after traumatic brain injury in rats. J Neurochem 2000; 74: 740-753
11. Schulz JB, Weller M, Moskowitz MA. Caspases as treatment targets in stroke and neurodegenerative diseases. Ann Neurol 1999; 45: 421-429
12. Storkebaum E, Carmeliet P. VEGF: A critical player in neurodegeneration. J Clin Invest 2004; 113: 14-18
13. Gerber HP, Dixit V, Ferrara N. Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells. J Biol Chem 1998; 273: 13313-13316 (Pubitemid 28246905)
14. Jin K, Mao XO, Batteur SP, et al. Caspase-3 and the regulation of hypoxic neuronal death by vascular endothelial growth factor. Neuroscience 2001, 108: 351-358
15. Hubold C, Oltmanns KM, Schultes B, et al. High plasma VEGF relates to low carbohydrate intake in patients with type 2 diabetes. Int J Obes (Lond) 2006; 30: 1356-1361
16. Liu XG, Feng YP. [Protective effect of dl-3-n-butylphthalide on ischemic neurological damage and abnormal behavior in rats subjected to focal ischemia]. Yao Xue Xue Bao 1995; 30: 896-903
17. Feng YP, Hu D, Zhang LY. [Effect of DL-butylphthalide (NBP) on mouse brain energy metabolism in complete brain ischemia induced by decapitation]. Yao Xue Xue Bao 1995; 30: 741-744
18. Dong GX, Feng YP. [Effects of NBP on ATPase and anti-oxidant enzymes activities and lipid peroxidation in transient focal cerebral ischemic rats]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2002; 24: 93-97
19. Xu HL, Feng YP. Inhibitory effects of chiral 3-n-butylphthalide on inflammation following focal ischemic brain injury in rats. Acta Pharmacol Sin 2000; 21: 433-438
20. Kunkler PE, Kraig RP. Reactive astrocytosis from excitotoxic injury in hippocampal organ culture parallels that seen in vivo. J Cereb Blood Flow Metab 1997; 17: 26-43
21. Gowing G, Philips T, van Wijmeersch B, et al. Ablation of proliferating microglia does not affect motor neuron degeneration in amyotrophic lateral sclerosis caused by mutant superoxide dismutase. J Neurosci 2008; 28: 10234-10244
22. Sonstein WJ, Kader A, Michelsen WJ, et al. Expression of vascular endothelial growth factor in pediatric and adult cerebral arteriovenous malformations: an immunocytochemical study. J Neurosurg 1996; 85: 838-845
23. Shi Y. Caspase activation, inhibition, and reactivation: A mechanistic view. Protein Sci 2004; 13: 1979-1987
24. Volm M, Mattern J, Koomagi R. Inverse correlation between apoptotic (Fas ligand, caspase-3) and angiogenic factors (VEGF, microvessel density) in squamous cell lung carcinomas. Anticancer Res 1999; 19: 1669-1671
25. Ryan CM. Neurobehavioral complications of type I diabetes. Examination of possible risk factors. Diabetes Care 1988; 11: 86-93
26. Low PA, Nickander KK, Tritschler HJ. The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy. Diabetes 1997; 46 (Suppl. 2): S38-S42
27. Baydas G, Nedzvetskii V S, Tuzcu M, et al. Increase of glial fibrillary acidic protein and S-100B in hippocampus and cortex of diabetic rats: Effects of vitamin E. Eur J Pharmacol 2003; 462: 67-71
28. Guastadisegni C, Minghetti L, Nicolini A, et al. Prostaglandin E2 synthesis is differentially affected by reactive nitrogen intermediates in cultured rat microglia and RAW 264.7 cells. FEBS Lett 1997; 413: 314-318
29. Endoh M, Maiese K, Wagner J. Expression of the inducible form of nitric oxide synthase by reactive astrocytes after transient global ischemia. Brain Res 1994; 651: 92-100
30. Shweiki D, Itin A, Soffer D, et al. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992; 359: 843-845
31. Flyvbjerg A, Khatir DS, Jensen LJ, et al. The involvement of growth hormone (GH), insulin-like growth factors (IGFs) and vascular endothelial growth factor (VEGF) in diabetic kidney disease. Curr Pharm Des 2004; 10: 3385-3394
32. Abumiya T, Lucero J, Heo JH, et al. Activated microvessels express vascular endothelial growth factor and integrin alpha(v)- beta3 during focal cerebral ischemia. J Cereb Blood Flow Metab 1999; 19: 1038-1050
33. Lee MY, Ju WK, Cha JH, et al. Expression of vascular endothelial growth factor mRNA following transient forebrain ischemia in rats. Neurosci Lett 1999; 265: 107-110
34. Plate KH, Beck H, Danner S, et al. Cell type specific upregulation of vascular endothelial growth factor in an MCA-occlusion model of cerebral infarct. J Neuropathol Exp Neurol 1999; 58: 654-666
35. Ransom B, Behar T, Nedergaard M. New roles for astrocytes (stars at last). Trends Neurosci 2003; 26: 520-522
36. Shweiki D, Neeman M, Itin A, et al. Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: Implications for tumor angiogenesis. Proc Natl Acad Sci USA 1995; 92: 768-772
37. Sone H, Kawakami Y, Okuda Y, et al. Vascular endothelial growth factor is induced by long-term high glucose concentration and up-regulated by acute glucose deprivation in cultured bovine retinal pigmented epithelial cells. Biochem Biophys Res Commun 1996; 221: 193-198
38. Thatte U, Dahanukar S. Apoptosis: Clinical relevance and pharmacological manipulation. Drugs 1997; 54: 511-532
39. Burke RE. Inhibition of mitogen-activated protein kinase and stimulation of Akt kinase signaling pathways: Two approaches with therapeutic potential in the treatment of neurodegenerative disease. Pharmacol Ther 2007; 114: 261-277
40. Jin KL, Mao XO, Greenberg DA. Vascular endothelial growth factor rescues HN33 neural cells from death induced by serum withdrawal. J Mol Neurosci 2000; 14: 197-203
41. Jin KL, Mao XO, Greenberg DA. Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia. Proc Natl Acad Sci USA 2000; 97: 10242-11027
42. Chang Q, Wang XL. Effects of chiral 3-n-butylphthalide on apoptosis induced by transient focal cerebral ischemia in rats. Acta Pharmacol Sin 2003; 24: 796-804
43. Peng Y, Xu S, Chen G, et al. l-3-n-Butylphthalide improves cognitive impairment induced by chronic cerebral hypoperfusion in rats. J Pharmacol Exp Ther 2007; 321: 902-910
44. Rouach N, Glowinski J, Giaume C. Activity-dependent neuronal control of gap-junctional communication in astrocytes. J Cell Biol 2000; 149: 1513-1526